This study revealed that early-stage CRC patients with LNM had a higher proportion of CD38+ NK cells, suggesting that the CD38+ NK cells was expected to be a potential marker for LNM in early-stage CRC. The gene discussed is CD38; the disease is colorectal carcinoma.